Currently out of the existing stock ratings of Donald Ellis, 29 are a BUY (93.55%), 2 are a HOLD (6.45%).

Donald Ellis

Work Performance Price Targets & Ratings Chart

Analyst Donald Ellis, carries an average stock price target met ratio of 52.92% that have a potential upside of 60.71% achieved within 484 days. Previously, Donald Ellis worked at JMP.

Donald Ellis’s has documented 65 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CLSD, Clearside Biomedical at 20-Dec-2021.

Wall Street Analyst Donald Ellis

Analyst best performing recommendations are on OCUL (OCULAR THERAPEUTIX).
The best stock recommendation documented was for OCUL (OCULAR THERAPEUTIX) at 11/12/2019. The price target of $7 was fulfilled within 113 days with a profit of $4.43 (172.37%) receiving and performance score of 15.25.

Average potential price target upside

of $19.21 (75.02%) on CLSD (CLEARSIDE BIOMEDICAL).
of $17.37 (45.08%) on PCRX (PACIRA PHARMACEUTICALS).
of $10.37 (22%) on AERI (AERIE PHARMACEUTICALS).

ACRS Aclaris Therapeutics AERI Aerie Pharmaceuticals ENDP Endo International PLC HZNP Horizon Pharma PLC CLSD Clearside Biomedical OCUL Ocular Therapeutix PCRX Pacira Pharmaceuticals SLGL Sol Gel Technologies Ltd EOLS Evolus

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Raghuram Selvaraju (HC WAINWRIGHT)